|
|
Volumn 25, Issue 9, 2007, Pages 949-
|
|
Retracing events
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
ETANERCEPT;
INFLIXIMAB;
PARVOVIRUS VECTOR;
PARVOVIRUS VECTOR 1;
PARVOVIRUS VECTOR 2;
UNCLASSIFIED DRUG;
ARTHRITIS;
CREATINE KINASE BLOOD LEVEL;
DRUG RESEARCH;
EDITORIAL;
GENE THERAPY;
HUMAN;
HYPERLIPOPROTEINEMIA TYPE 1;
LIVER TOXICITY;
PRIORITY JOURNAL;
SIDE EFFECT;
VIRUS REPLICATION;
ADVISORY COMMITTEES;
ANIMALS;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
CLINICAL TRIALS AS TOPIC;
DEPENDOVIRUS;
GENE THERAPY;
GENETIC VECTORS;
HUMANS;
|
|
EID: 70349727456
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0907-949 Document Type: Editorial |
|
Times cited : (11)
|
|
References (0)
|